Karohi C, Raggi P. Approach to cardiovascular disease prevention in patients with chronic kidney disease. Curr Treat Options Cardiovasc Med. 2012;14:391 413. 60. Acelajado MC, Calhoun DA, Oparil S. Pathogenesis of hypertension. In: Black H, Elliott W, eds. Hypertension: A Companion to Braunwald s Heart Disease. 2nd ed. Philadelphia, PA: Elsevier Sanders; 2012:12 26. 61. Tilg H, Moschen AR. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol. 2006;6:772 783. 62. Katagiri H, Yamada T, Oka Y. Adiposity and cardiovascular disorders: disturbance of the regulatory system consisting of humoral and neuronal signals. Circ Res. 2007;101:27 39. 63. Ding K, Kullo IJ. Genome-wide association studies for atherosclerotic vascular disease and its risk factors. Circ Cardiovasc Genet. 2009;2:63 72. 64. Abd El-Aziz TA, Hussein YM, Mohamed RH, Shalaby SM. Renin- angiotensin system genes polymorphism in Egyptians with premature coronary artery disease. Gene. 2012;498:270 275. 65. Konopka A, Szperl M, Piotrowski W, Roszczynko M, St pi ska J. Influence of renin-angiotensin system gene polymorphisms on the risk of ST-segment-elevation myocardial infarction and association with coro- nary artery disease risk factors. Mol Diagn Ther. 2011;15:167 176. 66. Tanner RM, Lynch AL, Brophy VH, Eckfeldt JH, Davis BR, Ford CE, Boerwinkle E, Arnett DK. Pharmacogenetic associations of MMP9 and MMP12 variants with cardiovascular disease in patients with hyperten- sion. PLoS One. 2011;6: e23609. 67. Manolio TA, Collins FS, Cox NJ, Goldstein DB, Hindorff LA, Hunter DJ, McCarthy MI, Ramos EM, Cardon LR, Chakravarti A, Cho JH, Guttmacher AE, Kong A, Kruglyak L, Mardis E, Rotimi CN, Slatkin M, Valle D, Whittemore AS, Boehnke M, Clark AG, Eichler EE, Gibson G, Haines JL, Mackay TF, McCarroll SA, Visscher PM. Finding the missing heritability of complex diseases. Nature. 2009;461:747 753. 68. Pimenta E, Calhoun DA, Oparil S. Cardiology. 